VANDA PHARMACEUTICALS INC. Other Noncash Income (Expense)
VANDA PHARMACEUTICALS INC. (VNDA) reported Other Noncash Income (Expense) of -$770.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$490.00K.
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$280.00K.
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2025-12-31 was $2.33M, a 234.86% increase year-over-year.
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$3.11M.
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for fiscal 2025 was -$1.94M.
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for fiscal 2024 was -$946.00K.
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for fiscal 2023 was -$2.10M.
- VANDA PHARMACEUTICALS INC. other noncash income (expense) for fiscal 2022 was -$2.46M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$490.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$770.00K 10-Q · filed 2026-08-06 | $1.56M derived: sum of 3 quarters · filed 2026-08-06 | -$1.54M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$280.00K 10-Q · filed 2026-05-07 | $2.05M derived: sum of 2 quarters · filed 2026-05-07 | -$1.05M derived: sum of 3 quarters · filed 2026-05-07 | -$1.22M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$772.00K derived: sum of 2 quarters · filed 2026-02-12 | -$935.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.94M 10-K · filed 2026-02-12 | |||
| 2025-09-30 | -$3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$3.27M derived: sum of 2 quarters · filed 2026-08-06 | -$4.28M 10-Q · filed 2025-10-30 | -$3.58M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.17M 10-Q · filed 2026-08-06 | -$2.89M 10-Q · filed 2025-07-31 | -$474.00K derived: sum of 3 quarters · filed 2026-08-06 | -$957.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$1.01M 10-Q · filed 2026-05-07 | -$1.85M 10-Q · filed 2025-05-08 | -$311.00K derived: sum of 2 quarters · filed 2026-05-07 | -$794.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.31M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $214.00K derived: sum of 2 quarters · filed 2026-02-12 | -$305.00K derived: sum of 3 quarters · filed 2026-02-12 | -$946.00K 10-K · filed 2026-02-12 | -$2.61M 10-K · filed 2025-02-14 | ||
| 2024-09-30 | -$483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$1.00M derived: sum of 2 quarters · filed 2025-10-30 | -$1.64M 10-Q · filed 2025-10-30 | -$966.00K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-06-30 | -$519.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$1.16M 10-Q · filed 2025-07-31 | -$483.00K derived: sum of 3 quarters · filed 2026-02-12 | -$1.41M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | -$641.00K 10-Q · filed 2025-05-08 | $36.00K derived: sum of 2 quarters · filed 2026-02-12 | -$892.00K derived: sum of 3 quarters · filed 2026-02-12 | -$1.63M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | $677.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$251.00K derived: sum of 2 quarters · filed 2026-02-12 | -$986.00K derived: sum of 3 quarters · filed 2026-02-12 | -$2.10M 10-K · filed 2026-02-12 | -$3.42M 10-K · filed 2024-02-08 | ||
| 2023-09-30 | -$928.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.66M derived: sum of 2 quarters · filed 2024-11-07 | -$2.77M 10-Q · filed 2024-11-07 | -$3.62M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-06-30 | -$735.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$1.84M 10-Q · filed 2024-08-01 | -$2.69M derived: sum of 3 quarters · filed 2025-02-14 | -$3.33M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-03-31 | -$1.11M 10-Q · filed 2024-05-09 | -$1.95M derived: sum of 2 quarters · filed 2025-02-14 | -$2.59M derived: sum of 3 quarters · filed 2025-02-14 | -$3.01M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2022-12-31 | -$844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$1.48M derived: sum of 2 quarters · filed 2025-02-14 | -$1.90M derived: sum of 3 quarters · filed 2025-02-14 | -$2.46M 10-K · filed 2025-02-14 | |||
| 2022-09-30 | -$637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.06M derived: sum of 2 quarters · filed 2023-11-09 | -$1.61M 10-Q · filed 2023-11-09 | -$2.12M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-06-30 | -$423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$975.00K 10-Q · filed 2023-07-28 | -$1.48M derived: sum of 3 quarters · filed 2024-02-08 | -$2.04M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-03-31 | -$552.00K 10-Q · filed 2023-05-03 | -$1.06M derived: sum of 2 quarters · filed 2024-02-08 | -$1.61M derived: sum of 3 quarters · filed 2024-02-08 | -$1.99M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2021-12-31 | -$506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | -$1.06M derived: sum of 2 quarters · filed 2024-02-08 | -$1.43M derived: sum of 3 quarters · filed 2024-02-08 | -$1.73M 10-K · filed 2024-02-08 | |||
| 2021-09-30 | -$556.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$927.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.22M 10-Q · filed 2022-11-03 | -$1.62M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-06-30 | -$371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$666.00K 10-Q · filed 2022-08-04 | -$1.06M derived: sum of 3 quarters · filed 2023-02-09 | -$1.73M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-03-31 | -$295.00K 10-Q · filed 2022-05-06 | -$692.00K derived: sum of 2 quarters · filed 2023-02-09 | -$1.36M derived: sum of 3 quarters · filed 2023-02-09 | -$1.74M derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2020-12-31 | -$397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$1.06M derived: sum of 2 quarters · filed 2023-02-09 | -$1.44M derived: sum of 3 quarters · filed 2023-02-09 | -$1.76M 10-K · filed 2023-02-09 | |||
| 2020-09-30 | -$666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$1.05M derived: sum of 2 quarters · filed 2021-11-04 | -$1.36M 10-Q · filed 2021-11-04 | -$1.63M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | -$381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$695.00K 10-Q · filed 2021-07-29 | -$963.00K derived: sum of 3 quarters · filed 2022-02-24 | -$1.74M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | -$314.00K 10-Q · filed 2021-05-06 | -$582.00K derived: sum of 2 quarters · filed 2022-02-24 | -$1.36M derived: sum of 3 quarters · filed 2022-02-24 | -$1.78M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$1.04M derived: sum of 2 quarters · filed 2022-02-24 | -$1.47M derived: sum of 3 quarters · filed 2022-02-24 | -$1.78M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$777.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$1.20M derived: sum of 2 quarters · filed 2020-10-29 | -$1.52M 10-Q · filed 2020-10-29 | -$1.53M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-06-30 | -$423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$740.00K 10-Q · filed 2020-08-06 | -$754.00K derived: sum of 3 quarters · filed 2021-02-11 | -$794.00K derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-03-31 | -$317.00K 10-Q · filed 2020-05-07 | -$331.00K derived: sum of 2 quarters · filed 2021-02-11 | -$371.00K derived: sum of 3 quarters · filed 2021-02-11 | -$597.00K derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2018-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$54.00K derived: sum of 2 quarters · filed 2021-02-11 | -$280.00K derived: sum of 3 quarters · filed 2021-02-11 | -$167.00K 10-K · filed 2021-02-11 | |||
| 2018-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$266.00K derived: sum of 2 quarters · filed 2019-11-07 | -$153.00K 10-Q · filed 2019-11-07 | -$341.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | -$226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$113.00K 10-Q · filed 2019-08-01 | -$301.00K derived: sum of 3 quarters · filed 2020-02-26 | -$490.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | $113.00K 10-Q · filed 2019-05-03 | -$75.00K derived: sum of 2 quarters · filed 2020-02-26 | -$264.00K derived: sum of 3 quarters · filed 2020-02-26 | -$341.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$377.00K derived: sum of 2 quarters · filed 2020-02-26 | -$454.00K derived: sum of 3 quarters · filed 2020-02-26 | -$587.00K 10-K · filed 2020-02-26 | |||
| 2017-09-30 | -$189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$266.00K derived: sum of 2 quarters · filed 2018-11-07 | -$399.00K 10-Q · filed 2018-11-07 | -$458.00K derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2017-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$210.00K 10-Q · filed 2018-08-02 | -$269.00K derived: sum of 3 quarters · filed 2019-02-19 | -$526.00K derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2017-03-31 | -$133.00K 10-Q · filed 2018-05-02 | -$192.00K derived: sum of 2 quarters · filed 2019-02-19 | -$449.00K derived: sum of 3 quarters · filed 2019-02-19 | -$663.00K derived: sum of 4 quarters · filed 2019-02-19 | |||
| 2016-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$316.00K derived: sum of 2 quarters · filed 2019-02-19 | -$530.00K derived: sum of 3 quarters · filed 2019-02-19 | -$542.00K 10-K · filed 2019-02-19 | -$646.00K 10-K · filed 2017-02-17 | ||
| 2016-09-30 | -$257.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$471.00K derived: sum of 2 quarters · filed 2017-11-08 | -$483.00K 10-Q · filed 2017-11-08 | -$307.00K derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-06-30 | -$214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$226.00K 10-Q · filed 2017-08-03 | -$50.00K derived: sum of 3 quarters · filed 2018-02-15 | -$395.00K derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-03-31 | -$12.00K 10-Q · filed 2017-05-03 | $164.00K derived: sum of 2 quarters · filed 2018-02-15 | -$181.00K derived: sum of 3 quarters · filed 2018-02-15 | -$256.00K derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2015-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$169.00K derived: sum of 2 quarters · filed 2018-02-15 | -$244.00K derived: sum of 3 quarters · filed 2018-02-15 | -$483.00K 10-K · filed 2018-02-15 | -$657.00K 10-K · filed 2016-02-12 | ||
| 2015-09-30 | -$345.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$420.00K derived: sum of 2 quarters · filed 2016-11-03 | -$659.00K 10-Q · filed 2016-11-03 | ||||
| 2015-06-30 | -$75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$314.00K 10-Q · filed 2016-07-28 | |||||
| 2015-03-31 | -$239.00K 10-Q · filed 2016-05-05 | ||||||
| 2014-12-31 | -$239.00K 10-K · filed 2017-02-17 | ||||||
| 2013-12-31 | -$104.00K 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |